Artiva Biotherapeutics, Inc. (ARTV) stock
ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.86−0.10 (-2.53%)
Close on Nov 17, 2026Market cap $188.72MP/E –Yield –
Artiva Biotherapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Artiva Biotherapeutics's enterprise value was -$234.27M on Nov 11, 2026, against -$131.46M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$234.27M | – |
| 2025 | Jan 31, 2025 | -$172.51M | – |
| 2024 | Dec 31, 2024 | -$145.86M | – |
See a number that looks wrong?